The Factors Affecting Atopic Dermatitis in Children Age 1-3
NCT ID: NCT04218877
Last Updated: 2022-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2020-03-10
2020-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis
NCT03559075
Short-term Topical Application to Prevent Atopic Dermatitis
NCT03871998
Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent Handbook
NCT03722706
Efficacy of the "Атопик Soothing Cream" in Children With Mild to Moderate Atopic Dermatitis
NCT02716181
Systemic Therapies for Pediatric Atopic Dermatitis
NCT01447381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with atopic dermatitis
Children 1-3 years old with atopic dermatitis
There will be no intervention, only observation
Children without atopic dermatitis
There will be no intervention, only observation
Children with genetic predisposition
Children with genetic predisposition to atopic dermatitis, but without manifestations
There will be no intervention, only observation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
There will be no intervention, only observation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* children 1-3 age with recurrent atopic dermatitis
Exclusion Criteria
* children age 1-2 with atopic dermatitis without rush during previous year
1 Year
3 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Akusherstvo Pro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amedclinic
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AkusherstvoPro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.